States Question Costs Of Middlemen That Manage Medicaid Drug Benefits
Several states are questioning the cost of using pharmacy middlemen to manage their prescription drug programs…Read More.
Medicare Part D premiums down, CMS says, as administration aims to curtail swelling drug costs
Premiums for nursing home residents’ prescription drug plans have dipped for the second year in a row, in what the administration hopes is a sign that efforts to curb prescription costs might be taking hold…Read More.
LTC Pharmacy Group Applauds House Energy and Commerce Committee Initiative to Review PBM Mergers
SCPC Thanks U.S. Reps Greg Walden (R-OR), Gregg Harper (R-MS), Michael Burgess (R-TX)…Read More.
LTC pharmacy group rips Medicare Part D ‘oligopoly, corrupting the free market,’ offers 7 fixes
One of the leading groups representing long-term care pharmacists is urging the federal government to “act swiftly” to address “skyrocketing drug costs” that are harming the field…Read More.
New Report: Generics, Not PBMs, Key Driver of Lower Prescription Drug Spending
SCPC Offers Reforms Boosting Competition, Enhancing Transparency in Consumer Drug Marketplace…Read More.
National LTC Pharmacy Group to HHS: Eliminate All POS and Post-POS Fees, Charges, Adjustments Paid by Pharmacies to PDPs/PBMs
SCPC Says Medicare Part D No Longer Operates in Free Market;
Notes Distinct Nature, Clinical Responsibilities of LTC Pharmacies…Read More.
It’s Generics Not PBMs That Keep Pharmaceuticals Affordable
Expenditures on prescription drugs grew 12.4 percent in 2014 and 8.9 percent in 2015. These eye-popping data are not representative of the long-term expenditure trend, however…Read More.
SCPC to Work with Senate to Advance Provision Recognizing Unique Status, Medication Needs of Hospice, Long Term Care (LTC) Patients
Praises U.S. House Support of HR 6, Effort by Rep. Roskam to Assist LTC and Hospice Patients…Read More.